Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition.

Caffeic acid phenethyl ester (CAPE) is an active component of propolis from honeybee. We investigated potential molecular mechanisms underlying CAPE-mediated nuclear factor kappa beta (NFkappaB) inhibition and analyzed structure of CAPE for its biological effect. CAPE attenuated expression of NFkappaB dependent luciferase stimulated with TNF-alpha or LPS and suppressed LPS-mediated induction of iNOS, a target gene product of NFkappaB. In HCT116 cells, CAPE interfered with TNF-alpha dependent IkappaBalpha degradation and subsequent nuclear accumulation of p65, which occurred by direct inhibition of inhibitory protein kappaB kinase (IKK). CAPE increased the expression of Nrf2-dependent luciferase and heme oxygenase-1, a target gene of Nrf2, and elevated the nuclear level of Nrf2 protein, indicating that CAPE activated the Nrf2 pathway. In HCT116 cells with stable expression of Nrf2 shRNA, CAPE elicited a reduced inhibitory effect on TNF-alpha-activated NFsmall ka, CyrillicB compared to scramble RNA expressing control cells. On the other hand, the NFkappaB inhibitory effect of CAPE was diminished by removal or modification of the Michael reaction acceptor, catechol or phenethyl moiety in CAPE. These data suggest that CAPE inhibits TNF-alpha-dependent NFkappaB activation via direct inhibition of IKK as well as activation of Nrf2 pathway, in which the functional groups in CAPE may be involved.

[1]  Yunjin Jung,et al.  Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication. , 2010, The Journal of nutritional biochemistry.

[2]  P. Maffia,et al.  Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. , 2002, Fitoterapia.

[3]  A. Kong,et al.  Modulatory Properties of Various Natural Chemopreventive Agents on the Activation of NF-κB Signaling Pathway , 2004, Pharmaceutical Research.

[4]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[5]  L. Fitzpatrick,et al.  Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. , 2001, The Journal of pharmacology and experimental therapeutics.

[6]  M. Schmitz,et al.  NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer , 2007 .

[7]  Chao-Chin Hu,et al.  Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. , 2005, The Journal of antimicrobial chemotherapy.

[8]  B. Lewis,et al.  Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. , 2002, Journal of agricultural and food chemistry.

[9]  Noula Shembade,et al.  Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. , 2007, The EMBO journal.

[10]  Tzong-Shyuan Lee,et al.  Induction of Heme Oxygenase-1 Expression in Murine Macrophages Is Essential for the Anti-inflammatory Effect of Low Dose 15-Deoxy-Δ12,14-prostaglandin J2* , 2003, Journal of Biological Chemistry.

[11]  T. Tsukamoto,et al.  Anti‐inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor‐κB inhibitor, on Helicobacter pylori‐induced gastritis in Mongolian gerbils , 2009, International journal of cancer.

[12]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[13]  K. Itoh,et al.  Transcription Factor Nrf2 Regulates Inflammation by Mediating the Effect of 15-Deoxy-Δ12,14-Prostaglandin J2 , 2004, Molecular and Cellular Biology.

[14]  A. Kong,et al.  Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. , 2005, Oncogene.

[15]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[16]  K. Itoh,et al.  Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). , 2004, Molecular and cellular biology.

[17]  A. Kong,et al.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. , 2008, Biochemical pharmacology.

[18]  M. Atkinson,et al.  Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. , 2004, The American journal of pathology.

[19]  Y. Xiong,et al.  A role for NEMO/IKKγ Ubiquitination in the activation of the IκB kinase complex by TNF-α , 2003 .

[20]  Jiankun Cui,et al.  Carnosic acid, a catechol‐type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S‐alkylation of targeted cysteines on Keap1 , 2008, Journal of neurochemistry.

[21]  M. Kwak,et al.  Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. , 2009, Free radical biology & medicine.

[22]  R. Barouki,et al.  Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[23]  J. Steer,et al.  Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL‐induced NF‐κB and NFAT activity , 2009, Journal of cellular physiology.

[24]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[25]  J. Christman,et al.  Redox Regulation of Nuclear Factor Kappa B: Therapeutic Potential for Attenuating Inflammatory Responses , 2000, Brain pathology.

[26]  S. Chae,et al.  Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells , 2008, Acta oto-laryngologica.

[27]  Y. Surh,et al.  15 -Deoxy -Δ12,14 -prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors , 2006 .

[28]  K. Tanaka,et al.  Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. , 2001, Biochimie.

[29]  Akira Kobayashi,et al.  Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism , 2006, Biological chemistry.

[30]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[31]  Chuanshu Huang,et al.  The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target , 2009 .

[32]  D. Kelleher,et al.  Caffeic acid phenethyl ester modulates Helicobacter pylori‐induced nuclear factor‐kappa B and activator protein‐1 expression in gastric epithelial cells , 2005, British journal of pharmacology.

[33]  Noula Shembade,et al.  Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signaling , 2007 .

[34]  R. Mancinelli,et al.  Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF‐κB and induction of apoptosis , 2009, International journal of cancer.

[35]  J. Pérez-Carreón,et al.  Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium‐term rat hepatocarcinogenesis assay , 2004, International journal of cancer.

[36]  Y. Xiong,et al.  A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α* , 2003, Journal of Biological Chemistry.

[37]  S. Chung,et al.  Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. , 2004, International immunopharmacology.

[38]  M. Schmitz,et al.  NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. , 2007, Current medicinal chemistry.

[39]  P. Baeuerle,et al.  NF‐kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. , 1991, The EMBO journal.

[40]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[41]  Y. Xiong,et al.  A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. , 2003, The Journal of biological chemistry.

[42]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Chuanshu Huang,et al.  The biological functions of NF-kappaB1 (p50) and its potential as an anti-cancer target. , 2009, Current cancer drug targets.

[44]  Jawed Alam,et al.  Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. , 2003, The Biochemical journal.

[45]  Ning Li,et al.  Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: implications for the impact of particulate pollutants on asthma. , 2006, Antioxidants & redox signaling.